Growth Metrics

Dna X (SONM) Shares Outstanding (Weighted Average) (2018 - 2025)

Dna X's Shares Outstanding (Weighted Average) history spans 8 years, with the latest figure at $722689.0 for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $722689.0 for Q4 2025, up 175.71% from a year ago — trailing twelve months through Dec 2025 was $722689.0 (up 175.71% YoY), and the annual figure for FY2025 was $722689.0, up 175.71%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $722689.0 at Dna X, up from $614985.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $40.9 million in Q1 2023 to a low of $258788.0 in Q3 2024.
  • The 5-year median for Shares Outstanding (Weighted Average) is $6.2 million (2021), against an average of $10.7 million.
  • The sharpest move saw Shares Outstanding (Weighted Average) soared 399.62% in 2022, then plummeted 93.99% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $9.5 million in 2021, then skyrocketed by 205.23% to $28.9 million in 2022, then plummeted by 85.16% to $4.3 million in 2023, then plummeted by 93.89% to $262118.0 in 2024, then soared by 175.71% to $722689.0 in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $722689.0, $614985.0, and $9.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.